Overview
Portfolio
More
Alwyn Capital
Alwyn Capital invests in early‑stage biotechnology companies developing plant‑based proteins, cultivated meat, fermentation, recombinant technologies and non‑animal materials, including organ‑on‑chip models. They aim to...
Portfolio
16+
Employees
3+
Founded
2018
AUM
≈ $500.0M
Investment focus
Stages
Pre-Seed → Seed
Industries
Biotechnology
Fund details
Funds
Alwyn Capital Fund I
Vintage 2024
Sources
Alwyn Capital
Alwyn Capital invests in early‑stage biotechnology companies developing plant‑based proteins, cultivated meat, fermentation, recombinant technologies and non‑animal materials, including organ‑on‑chip models. They aim to reduce dependence on animals, addressing climate and human health challenges.
Portfolio
16+
Employees
3+
Founded
2018
AUM
≈ $500.0M
Funds
Alwyn Capital Fund I · Vintage 2024
Showing 14 of 14 matched portfolio companies
This startup produces plant-based meat alternatives using whole food ingredients, including vegetables, herbs, and spices, to create products like vegan burgers and deli slices. By offering affordable options, the company addresses the demand for sustainable and health-conscious protein sources in the market.
Funding: $19.1M
Rough estimate of the amount of funding raised
Funding: $19.1M
Rough estimate of the amount of funding raised
This company produces clean, cultivated seafood by growing fish muscle cells, offering a highly scalable and sustainable alternative to traditional fishing. Their product is nutritious, high in Omega-3s, and free from common contaminants like mercury and microplastics. They provide a consistent, premium domestic supply of seafood to address global overfishing concerns.
Funding: $780.0K
Rough estimate of the amount of funding raised
North Carolina Biotechnology Center
North Carolina Biotechnology Center
Funding: $780.0K
Rough estimate of the amount of funding raised
The startup develops alternative protein sources by utilizing protein-yielding yeast strains and efficient bioprocesses in capital-light fermentation facilities. This approach produces nature-identical animal proteins at a low cost, addressing the demand for affordable and sustainable protein options in food and human health.
5+
100+Approximate amount of employees
Funding: $260.0K
Rough estimate of the amount of funding raised
Funding: $260.0K
Rough estimate of the amount of funding raised
Avant Meats utilizes patent-pending cell cultivation technology to produce fish products without the need for traditional fishing methods, ensuring they are free from heavy metals and microplastics. This approach addresses the depletion of ocean fish stocks by providing a sustainable and scalable alternative for nutritious seafood.
Funding: $16.9M
Rough estimate of the amount of funding raised
S2G Ventures
S2G Ventures
Funding: $16.9M
Rough estimate of the amount of funding raised
BlueNalu utilizes cellular aquaculture technology to produce cell-cultured seafood, starting with bluefin tuna toro, which eliminates the need for overfishing and reduces exposure to contaminants found in conventional seafood. This approach provides a consistent, high-quality alternative that supports ocean regeneration while delivering safe and nutritious seafood products.
Funding: $118.0M
Rough estimate of the amount of funding raised
Funding: $118.0M
Rough estimate of the amount of funding raised
The startup utilizes a versatile platform that combines plant-based and cultivated meat technologies to produce precision-structured, slaughter-free chicken whole cuts. This approach addresses the demand for high-quality meat alternatives that replicate the sensory properties and nutritional value of traditional meat without the ethical and environmental concerns associated with animal slaughter.
Funding: $10.0K
Rough estimate of the amount of funding raised
Humane Entrepreneurship Program
Humane Entrepreneurship Program
Funding: $10.0K
Rough estimate of the amount of funding raised
This biodesign company develops animal-free designer proteins that are sustainably cultivated and clinically validated for performance. Their products enable businesses to create environmentally friendly alternatives, supporting a transition to a plant-based future.
This startup produces plant-based seafood substitutes that replicate the texture, flavor, and nutritional profile of traditional seafood using proprietary formulation techniques. By providing whole-muscle alternatives, the company caters to the growing demand for sustainable and ethical food options while addressing concerns over overfishing and marine ecosystem degradation.
Funding: $18.0M
Rough estimate of the amount of funding raised
Good Startup
Good Startup
Funding: $18.0M
Rough estimate of the amount of funding raised
Paragon Pure develops plant-based food ingredients, including OléBK, a palm oil alternative derived from upcycled rice bran, and SproutedByNature rice flour, which replaces maltodextrin and corn syrup for healthier formulations. These products address the demand for sustainable and nutritious food options while enhancing the taste and health profile of various food applications.
Funding: $4.0M
Rough estimate of the amount of funding raised
Unovis Asset Management
Unovis Asset Management
Funding: $4.0M
Rough estimate of the amount of funding raised
Rheom Materials develops sustainable material alternatives by pioneering the use of biopolymers derived from plant-based matter. The company utilizes advanced melt extrusion techniques to process and modify these biobased components for compatibility across various manufacturing processes. This platform enables scalable, local production of sustainable materials for the fashion, electronics, and automotive sectors.
Funding: $2.2M
Rough estimate of the amount of funding raised
Funding: $2.2M
Rough estimate of the amount of funding raised
The startup offers an automated protein manufacturing system that enables users to produce biologics efficiently and cost-effectively. This technology addresses the lengthy development cycles and high costs associated with creating new medicines and bio-based products.
Funding: $3.6M
Rough estimate of the amount of funding raised
SK Bioscience
SK Bioscience
Funding: $3.6M
Rough estimate of the amount of funding raised
The startup has developed a scalable cell separation technology utilizing multiplexed microfluidic devices for industrial-scale liquid particle processing, including cell separation and pathogen concentration. This technology offers a cost-effective alternative to traditional methods such as filtration, flow centrifugation, and flocculation, significantly enhancing throughput and efficiency in various industries.
Funding: $4.7M
Rough estimate of the amount of funding raised
Thia Ventures
Thia Ventures
Funding: $4.7M
Rough estimate of the amount of funding raised
This biomaterials company develops next-generation, sustainable alternatives to animal leather using grain-based components. Their proprietary BioFuze technology platform replicates collagen structure to create high-quality, customizable materials. The resulting products offer durability and luxury aesthetics while being scalable, tanning-free, and environmentally conscious.
Funding: $7.6M
Rough estimate of the amount of funding raised
Fall Line CapitalGreen Circle Foodtech Ventures
Fall Line CapitalGreen Circle Foodtech Ventures
Funding: $7.6M
Rough estimate of the amount of funding raised
UPSIDE Foods cultivates animal cells to produce chicken, beef, duck, and seafood products without raising or slaughtering animals. Using a master cell bank and animal‑component‑free feed, the company scales bioreactor production to supply restaurants and food‑service distributors with FDA‑cleared cultivated meat that lowers land, water, and greenhouse‑gas impacts.
U.S. Department of Agriculture
Showing 2 of 2 unmatched portfolio companies